Correspondence to: Dr R Ellul-Micallef, L'Arc-en-Ciel, San Anton Estate, Attard, Malta. establishing the underlying cause. Although cough, dyspnoea, and wheezing constitute the triad of classical symptoms of asthma, cough may precede the other symptoms or indeed be the sole manifestation of an allergic state, and this is often overlooked. In Kuwait chronic intractable cough, frequently non-productive, is common, particularly during the spring and summer.4 In the present study I assessed the effects of terbutaline sulphate in 30 patients who presented at an allergy outpatient clinic with chronic cough in the absence of dyspnoea.
Patients and methods
I studied 30 patients attending the allergy outpatient clinic over three years. They were prospectively selected if they presented with a chronic cough of at least three months' duration that was unaccompanied by dyspnoea or wheezing. None of the patients smoked or had any evidence of lung disease. The table shows clinical and physiological data on the patients studied. After a careful physical examination all patients underwent radiography of the chest and sinuses and electrocardiography. Bacteriological examination of the sputum was carried out whenever the cough was productive. In addition, blood specimens were examined for eosinophils, and prick skin tests with a wide variety of allergens were performed. No patient had been receiving antiasthma treatment before referral to the clinic. Most had previously received multiple courses of different antibiotics, antitussives, decongestants, and antihistaminics with no effect.
Before admission to the study reversibility of any airflow obstruction present was tested for with a dry wedge spirometer (Vitalograph), the forced expiratory volume in one second being measured before and after two puffs of a metered dose of terbutaline sulphate. Patients with normal spirometric values underwent histamine inhalation challenge with a standardised procedure5 on a separate occasion. After a three week baseline period patients were randomly assigned to receive 2 5 mg terbutaline sulphate or a placebo tablet three times a day for three weeks; they then received the alternative preparation for three weeks. The study was carried out under double blind crossover conditions. The patients were given diary cards to record the severity of their day and night cough. Day cough was scored as 0 if cough had been absent, 1-3 if it was mild, 4-6 if moderate, 7-9 if severe, and 10 if utterly exhausting. Similarly, night cough was scored as 0 if the patient 941 ranged from 20,) to 220' (mean 12 6 (6)0'). In all 24 patients in whom the initial forced expiratory volume in one second was greater than 850o of the predicted value a histamine inhalation challenge test resulted in a fall in forced expiratory volume in one second of at least 20°h, indicating the presence of bronchial hyperresponsiveness (table) . In general, the lower the provocative histamine concentration that induced a 20°o1 fall in forced expiratory volume in one second the greater the increase in forced expiratory volume in one second after salbutamol. When the forced expiratory volume in one second increased by more than 150% after salbutamol the provocative concentration that induced a 20°/ fall was always less than 0 5 g/l.
Analysis of the day and night weekly cough scores showed that In the group as a whole peak expiratory flow rates (fig 2) showed no significant change when the patients took placebo (p < 1) but increased when they took terbutaline (p < 0 05).
Discussion
Colmes was the first to indicate that cough could be an independent symptom of allergy when he described a case due to "hypersensitiveness to Orris" 7; three further cases were reported a year later.8 It has only recently been re-emphasised that cough may be a variant of asthma and precede the classical picture.9-1" Several reports have now been published showing the efficacy of bronchodilators in relieving this type of cough, but no placebo controlled, double blind trial has been carried out. The number of adults studied has been small,9 11 but one study of a fair number of children has been reported.'2 Different types of cough occur in man, and little is known about their causative mechanisms2: it appears that irritation of subepithelial receptors by various stimuli may result directly in cough via vagal pathways"3 or may indirectly cause local narrowing of airways, which subsequently triggers off the cough reflex.'4 In the present study bronchial hyperresponsiveness was present in all the patients who underwent histamine challenge. It is now firmly established that bronchodilators reduce bronchial responsiveness""-17 even when they produce no demonstrable bronchodilatation.'7 18 Although cholinergic reflexes play a part in bronchial hyperresponsiveness,'9 a neurological mechanism does not account for all the features.20 Other factors, such as an intrinsic abnormality in bronchial smooth muscle, have been postulated.21 22 Recent evidence, however, seems to indicate that bronchial hyperresponsiveness is an in vivo phenomenon resulting from factors other than hypersensitivity of bronchial smooth muscle to mediator release.2' Terbutaline may have produced its antitussive effect in the present patients by decreasing bronchial responsiveness. This may well have been the result of its non-specific effect of bronchodilatation.l8 '3In addition, it may have also acted on several mucosal structures, including epithelial tight junctions and irritant nerve endings, as well as on mast cells, thus reducing mediator release.24 25 Terbutaline sulphate abolished the cough in most patients in this study within a week of the start of treatment. The appreciable decrease in cough scores was achieved with fairly small changes in airway calibre. A carry over effect was seen in several patients who changed from the active drug to placebo, but cough had returned in all cases by the fifth day of the first placebo week. This carry over effect was reflected by the overall lower day and night cough scores recorded in the first placebo week. The values shown in the figures represent recordings obtained before any prednisolone treatment. The nine patients in whom terbutaline failed to bring about a satisfactory response had all suffered from cough for at least two years. Corticosteroids probably brought about a remission of symptoms through their anti-inflammatory action, reducing mucosal permeability and thereby denying access to the irritant receptors in the epithelia and mast cells in the submucosa. Corticosteroids have been reported to alleviate severe cough in children with pertussis.26
All the patients in the group who knew how to use an inhaler properly were subsequently given aerosol treatment as this has been shown to afford the best protection in inhalation'6 and exercise27 challenge tests. A follow up study is under way to determine whether the classical picture of asthma will eventually develop in these patients who originally presented with cough as their sole complaint.
(Accepted 12_7uly 1983) Fetal distress and the condition of newborn infants G S SYKES, PAULA M MOLLOY, P JOHNSON, G M STIRRAT, A C TURNBULL Abstract In a prospective audit of the obstetric management of 1210 consecutive deliveries the association was investigated between the need for operative delivery for fetal distress during labour and the condition of the newborn infant. Operative delivery was performed for only 11 5% of the newborn infants with severe acidosis at birth (umbilical artery pH <7 12, base deficit >12 mmol (mEq)/l), 241% of those with an Apgar score <7 at one minute, and 15 8% of those with both severe acidosis and a one minute Apgar score <7. Most of the infants delivered operatively were in a vigorous condition at birth and did not have severe acidosis. Fetal blood sampling was done in 4 0% of labours. As none of the fetal blood values were less than 7 20 and only three of the infants sampled in utero suffered severe acidosis at birth, fetal blood sampling would have had to be performed much more often to provide a useful guide to metabolic state at birth. While the large majority of "at risk" fetuses had continuous fetal heart rate monitoring in labour, this had not been provided in 48 7% of the labours of infants with severe acidosis, 38 7% of infants with a one minute Apgar score <7, and 474% of infants with both severe acidosis and a one minute Apgar score <7. Continuous fetal heart rate monitoring was associated with a much higher incidence of operative delivery for fetal distress than was intermittent fetal heart rate auscultation.
These results suggest an urgent need to review present methods for assessing the intrapartum condition of the fetus, making the diagnosis of fetal distress, and assessing the condition of the infant at birth.
Introduction
Fetal distress is a relatively common indication for operative delivery. The diagnosis is usually based on characteristic changes in fetal heart rate assessed by auscultation or electronic recording with, in some cases, low pH in a fetal blood sample.1-3 At this hospital continuous monitoring of fetal heart rate is done largely in only "at risk" labours, as the results of randomised controlled trials of fetal monitoring4-8 are not considered to justify a policy of extending continuous fetal heart rate monitoring to all. Analysis of umbilical cord blood samples of at risk newborn infants showed that their acid base state at delivery was not related to the clinical diagnosis of fetal distress, raising doubts about the effectiveness of intrapartum fetal surveillance. Since severe fetal metabolic acidosis due to hypoxia is thought to be important in asphyxial damage in the newborn,3 9 and since it was not known how closely clinical diagnosis of fetal distress was associated with severe acidosis at birth or the clinical condition of the newborn infant, a prospective audit of these factors was conducted in 1000 consecutive deliveries managed by routine methods.
Methods
The clinical condition of newborn infants was assessed by Apgar score and their biochemical condition by measuring umbilical artery blood values. Umbilical cords were double clamped immediately after delivery, samples collected anaerobically into preheparinised polyethylene syringes, and were analysed as soon as possible using an ABL-3 Acid-Base Laboratory (Radiometer, Copenhagen). If immediate analysis was not possible the capped syringes were immersed in crushed ice and stored in the refrigerator. In this study umbilical artery pH and base deficit were investigated, as they provide a reliable indication of the degree of fetal tissue metabolism at delivery. "Severe acidosis" was defined as being present when both umbilical artery pH and base excess measurements were one standard deviation below the mean of the population studied.
Patient management was not modified in any way during the audit period. All information was obtained by scrutinising the case notes and stored fetal heart rate recordings. When the primary indication for operative delivery was fetal distress a newborn infant was classified as having had an "operative delivery for fetal distress." The obstetrician's diagnosis of fetal distress was usually based on concern about the fetal heart rate, occasionally on fetal blood pH, and sometimes on other observations. The usual indications for continuous fetal heart rate monitoring were poor obstetric history, hypertension, pre-eclampsia, diabetes, antepartum haemorrhage, intrauterine growth retardation, prematurity, malpresentation, epidural anaesthesia, oxytocin infusion, meconium stained liquor, an auscultated fetal heart rate < 120 beats/min, > 160 beats/min, or with excessive irregularity, "trial of scar," and "trial of labour"; however, the decision about the method of fetal heart rate monitoring was made
